Apex Capital Management’s Chemed CHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
$17.6M Buy
130,220
+20,440
+19% +$2.76M 0.39% 76
2015
Q4
$16.4M Buy
109,780
+8,918
+9% +$1.32M 0.37% 79
2015
Q3
$13.5M Buy
100,862
+8,558
+9% +$1.2M 0.3% 84
2015
Q2
$12.1M Buy
92,304
+11,296
+14% +$1.4M 0.26% 89
2015
Q1
$9.67M Buy
81,008
+19,880
+33% +$2.21M 0.23% 94
2014
Q4
$6.46M Buy
61,128
+14,647
+32% +$1.55M 0.17% 109
2014
Q3
$4.78M Buy
+46,481
New +$4.71M 0.14% 118

Other funds holding CHE

Apex Capital Management's CHE Position: Q1 2016 in Review

Apex Capital Management increased its Chemed (CHE) stake by 19% in Q1 2016, buying an estimated $2.76M and bringing the position to 130,220 shares worth $17.6M. The position accounts for 0.39% of the portfolio, ranked #76.

Apex Capital Management first reported a position in CHE in Q3 2014 and has held it in 7 quarters since. 236 funds tracked by Wall St. Rank hold CHE as of Q1 2016.

  • Apex Capital Management held 130,220 shares of Chemed worth $17.6M as of Q1 2016.
  • Apex Capital Management bought 20,440 Chemed shares in Q1 2016, an estimated $2.76M.
  • Chemed made up 0.39% of Apex Capital Management's portfolio in Q1 2016, its #76 holding.
  • Apex Capital Management first reported a position in Chemed in Q3 2014 and has held it in 7 quarters since.
  • 236 funds tracked by Wall St. Rank held Chemed as of Q1 2016.

Based on Apex Capital Management's 13F filing for Q1 2016, filed 27 Apr 2016.